Gemmer Asset Management LLC Fulgent Genetics, Inc. Transaction History

Gemmer Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$47.98 - $62.75 $8,972 - $11,734	-187 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$77.3 - $105.0 $14,455 - $19,635	187 New	187 $19,000
Q2 2021 Jul 23, 2021	SELL	$66.8 - $100.45 $1,202 - $1,808	-18 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$59.3 - $183.85 $2,787 - $8,640	-47 Reduced 72.31%	18 $2,000
Q4 2020 Jan 28, 2021	SELL	$31.01 - $52.1 $1,860 - $3,126	-60 Reduced 48.0%	65 $3,000
Q3 2020 Oct 21, 2020	SELL	$15.89 - $50.51 $1,191 - $3,788	-75 Reduced 37.5%	125 $5,000
Q2 2020 Jul 31, 2020	SELL	$8.89 - $18.28 $1,778 - $3,656	-200 Reduced 50.0%	200 $3,000
Q1 2020 May 01, 2020	BUY	$6.75 - $19.75 $2,700 - $7,900	400 New	400 $4,000

195

15.3M

1.07M

27.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $676M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.